Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Income from Non-Controlling Interests (2016 - 2019)

Historic Income from Non-Controlling Interests for Lisata Therapeutics (LSTA) over the last 10 years, with Q3 2019 value amounting to $1000.0.

  • Lisata Therapeutics' Income from Non-Controlling Interests changed 0.0% to $1000.0 in Q3 2019 from the same period last year, while for Sep 2023 it was $1000.0, marking a year-over-year change of. This contributed to the annual value of $9000.0 for FY2020, which is 0.0% changed from last year.
  • Per Lisata Therapeutics' latest filing, its Income from Non-Controlling Interests stood at $1000.0 for Q3 2019, which was down 0.0% from $3000.0 recorded in Q2 2019.
  • Over the past 5 years, Lisata Therapeutics' Income from Non-Controlling Interests peaked at $3000.0 during Q2 2019, and registered a low of -$368831.0 during Q1 2017.
  • Its 5-year average for Income from Non-Controlling Interests is -$71625.4, with a median of -$31292.0 in 2015.
  • Per our database at Business Quant, Lisata Therapeutics' Income from Non-Controlling Interests plummeted by 194429.26% in 2016 and then surged by 40000.0% in 2019.
  • Quarter analysis of 5 years shows Lisata Therapeutics' Income from Non-Controlling Interests stood at -$31292.0 in 2015, then crashed by 144.58% to -$76533.0 in 2016, then skyrocketed by 98.9% to -$844.0 in 2017, then skyrocketed by 218.48% to $1000.0 in 2018, then changed by 0.0% to $1000.0 in 2019.
  • Its Income from Non-Controlling Interests was $1000.0 in Q3 2019, compared to $3000.0 in Q2 2019 and $2000.0 in Q1 2019.